Hologic, Inc. provided earnings guidance for the third quarter of fiscal 2024. For the quarter, the Company expects revenues of $992.5 million to $1,007.5 million and GAAP EPS of $0.80 to $0.87.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.36 USD | -0.60% | -1.60% | +2.67% |
May. 22 | FDA classifies recall of Hologic's implant as 'most serious' | RE |
May. 22 | FDA classifies recall of Hologic's implants for soft tissue as 'most serious' | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.67% | 17.22B | |
+7.87% | 223B | |
+11.83% | 195B | |
+18.87% | 144B | |
+30.03% | 111B | |
+2.32% | 65.19B | |
+14.15% | 53.02B | |
+2.68% | 50.28B | |
+6.60% | 44.15B | |
+1.85% | 36.45B |
- Stock Market
- Equities
- HOLX Stock
- News Hologic, Inc.
- Hologic, Inc. Provides Earnings Guidance for the Third Quarter of Fiscal 2024